Stanford University
Showing 951-1,000 of 2,652 Results
-
Chaitanya K. Joshi
Postdoctoral Scholar, Biochemistry
BioI'm a Stanford Data Science Fellow and Postdoc at the Department of Biochemistry, working with Prof. Rhiju Das. I'm building lab-in-the-loop AI for RNA biology, bridging deep learning and high-throughput wet lab experiments at scale.
Previously, I completed my PhD in Computer Science at the University of Cambridge with Prof. Pietro Liò. My doctoral work focused on Geometric Deep Learning for molecular modelling and design. As a highlight, I developed gRNAde, an inverse design framework that we used to design and experimentally validate new functional RNA enzymes in collaboration with Dr. Phil Holliger's group at MRC LMB. My research has been recognized by the Qualcomm Innovation Fellowship and the A*STAR National Science Scholarship. I've also been a research scientist intern at Prescient Design (Genentech) and FAIR Chemistry (Meta AI) during my PhD. -
Israel Juarez Contreras
Postdoctoral Scholar, Biochemistry
BioI am a postdoctoral scholar in the lab of Rajat Rohatgi at Stanford University, where I study how membrane organization controls sterol accessibility and signaling. I earned my Ph.D. at UC San Diego with Itay Budin, where I uncovered how sterol structure and sphingolipid composition regulate membrane phase behavior in yeast and reconstituted systems. My current work translates these biophysical principles into disease-relevant contexts, with a focus on lysosomal lipid organization and sterol trafficking defects, including those associated with NPC1. Ultimately, I aim to establish an independent research program that defines how cells interpret membrane physical properties and how their dysregulation contributes to human disease.
-
Seraphine Kamayirese
Postdoctoral Scholar, Bioengineering
BioI am a protein and peptide biochemist with a focus on biophysical characterization, structural activity relationship (SAR)study, and design and optimization of peptides targeting disease-relevant proteins. My Ph.D. research focused on designing and optimizing ligands that target the 14-3-3ε protein to disrupt its interaction with the cell cycle regulator CDC25A, an interaction known to suppress apoptosis in squamous cell carcinoma. Inhibiting this pathway is expected to promote apoptosis in cutaneous squamous cell carcinoma. At Stanford University, I am expanding my research to study antimicrobial peptidoids and peptides such as LL-37 and their interactions with amyloid beta peptides, and the potential application of the resulting complexes as antiviral therapeutics. I bring strong experience in rational peptide design, structural activity relationship studies, molecular dynamics simulations, peptides and peptoids synthesis and purification, protein expression, and biophysical assays. My research has led to multiple peer-reviewed publications, presentations at national and international conferences, and awards, including the Young Investigator Poster Award at the American Peptide Symposium.
-
Vanessa W.Y. Kan
Postdoctoral Scholar, Neurosurgery
BioI am a second-year postdoctoral researcher in Irene Llorente’s laboratory at the Department of Neurosurgery. I completed my Ph.D. at the Graduate School of Systemic Neurosciences GSN-LMU in Munich, Germany, where I was trained as a circuit neuroscientist. During my doctoral work, I focused on dissecting the circuit mechanisms underlying cortical hyperexcitability in ALS, uncovering the pathophysiological role of hyper-responsive layer 2⁄3 neurons (one of the main inputs to layer 5) in the disease course. Currently, my research bridges circuit neuroscience, stem cell biology, and bioinformatics to explore mechanisms of neural repair and regeneration. I utilize advanced experimental and computational tools, including in vivo calcium imaging in awake, freely behaving rodents; machine learning-based motion sequencing (MoSeq); anterograde and retrograde viral tracing techniques; and transplantation of iPSC-derived glial-enriched progenitors and cortical interneurons. In parallel, I apply spatial transcriptomics and single-cell RNA sequencing to map cell-type–specific interactions and molecular signatures during neural circuit remodeling.
My research focuses on understanding the circuit mechanisms underlying neurological conditions such as stroke and identifying how cell-based therapies mediate repair. The ultimate goal of my work is to uncover molecular and cellular processes that promote graft–host integration and functional recovery, paving the way for next-generation regenerative therapies for the injured brain.
In addition to translational research, I am also passionate about scientific education and outreach. I mentor community college students twice a year through the Stanford Science Small Group, in which I share my own experience in research and guide them through the research process. To expand my outreach efforts, in the past summer, I collaborated with Invent Your Own Future as well as The Hong Kong Polytechnic University and organized a summer camp on Neuroscience x AI research for over 20 high school students in Hong Kong. -
Vishnu Priya Kanakaveti
Postdoctoral Scholar, Oncology
Current Research and Scholarly InterestsI am interested in elucidating molecular mechanisms of MYC-driven drug resistance and immune evasion in cancer using computational and experimental models.
-
Kathryn (Katie) Kapp
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI am interested in using mass spectrometry to study protein glycosylation, a complex post-translational modification that is known to be heavily altered in cancer and could improve early cancer detection. I am using mass spectrometry to study protein glycosylation in a variety of clinical samples and cancers, but I am particularly interested in proximal fluid samples to develop more accessible ways to obtain clinical samples to study cancer and women's health.
-
James Regun Karmoker
Postdoctoral Scholar, Ophthalmology
BioDr. James Regun Karmoker started his career as a Lecturer at the University of Asia Pacific, Bangladesh, after completing his B. Pharm and MS Pharm Tech from the same university. He obtained a doctorate degree in Vision Science from the University of Oklahoma, USA, where he studied immune cell activation in the context of retinal pigment epithelium injury. Currently, he is a postdoctoral scholar in Prof. Mary Elizabeth Hartnett’s lab studying age-related macular degeneration.
-
Siva Kasinathan
Instructor, Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD is a physician-scientist and Instructor of Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to caring for children and young adults with rheumatic diseases in his clinical practice, Siva conducts research to advance the understanding of mechanisms of autoimmunity and autoinflammation.
Siva holds an MD and PhD in Molecular and Cell Biology from the University of Washington, where he developed several high-throughput methods for epigenome profiling and contributed new insights in chromatin biology and gene regulation. During his clinical training in pediatrics and rheumatology at Stanford, Siva pioneered approaches for single-molecule analysis of genetic variation, DNA methylation, and chromatin structure, and established a longitudinal rheumatic disease cohort and biorepository.
Siva’s current research bridges genomics and immunology with a focus on developing and applying sensitive technologies to unravel the genetic and molecular underpinnings of lupus, arthritis, and other immune-mediated diseases. As a physician-scientist, Siva is committed to translating fundamental discoveries into precision therapies and biomarkers to improve outcomes for patients with rheumatic diseases. -
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions.
